Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$9.16M
↑ 121% above average
Average (9y)
$4.14M
Historical baseline
Range
High:$13.97M
Low:$388000.00
CAGR
+23.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $9.16M | +10.8% |
| 2023 | $8.27M | -40.8% |
| 2022 | $13.97M | +465.8% |
| 2021 | $2.47M | +536.6% |
| 2020 | $388000.00 | -63.6% |
| 2019 | $1.07M | -4.3% |
| 2018 | $1.11M | -31.4% |
| 2017 | $1.62M | -14.3% |
| 2016 | $1.89M | +32.7% |
| 2015 | $1.43M | - |